Clinical Trial Update: Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the acute impact of intramuscular aripiprazole and intramuscular olanzapine on insulin resistance in individuals with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• olanzapine (olanzapine)

Snippet

Sponsor: Veterans Medical Research Foundation | Conditions: Diabetes | Phase 4 | Status: COMPLETED